Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Some treatments like minoxidil, finasteride, and surgery can help with hereditary hair loss.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

PCOS in women from Karnataka is influenced by genetics, family history, and insulin resistance, requiring better diagnosis and treatment.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Metformin helps treat PCOS by improving fertility, reducing symptoms, and regulating periods.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.